Medtronic bought Epix for a catheter-based, temperature-controlled cardiac ablation system designed to treat patients with irregular heartbeats including atrial fibrillation. Two years after making the deal, Medtronic received U.S. Food and Drug Administration approval for the device.
To acquire DiamondTemp, Medtronic also had to take on Epix’s Sunnyvale facility and employees. Now, similar to 20 years ago when Medtronic bought PercuSurge and closed its Sunnyvale site, the company has decided to move on without Epix’s former facility and employees.
